Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Earlier Reported, ‘Micron Regards Taiwan As Main EUV DRAM Production Base’ – DigiTimes

Taiwan will be Micron Technology's main EUV DRAM manufacturing base, according to Donghui Lu, head of Micron Taiwan.
byBenzinga Newsdesk
December 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Taiwan will be Micron Technology’s main EUV DRAM manufacturing base, according to Donghui Lu, head of Micron Taiwan.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

CymaBay Therapeutics Announced Collaboration with Kaken Pharmaceutical to Develop and Commercialize Seladelpar in Japan for Primary Biliary Cholangitis; Kaken to Make Upfront Payment To Cymabay Of ~$34M Plus Milestone Payments Up To ~$128.4M And Royal…

By Charles Gross
January 8, 2:17 PM
CymaBay Therapeutics, Inc. (NASDAQ: CBAY) announced today that it has entered into a collaboration and license agreement with Kaken Pharmaceutical Co., Ltd. ("Kaken") for the development and commercialization in Japan of CymaBay's investigational drug seladelpar for the treatment of primary biliary cholangitis ("PBC").

CBAY